XML 23 R46.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Commitments and Contingencies (Details) (USD $) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2013 | Dec. 31, 2012
Abbott Biotherapeutics Corp [Member] | Phase I Clinical Trial of a licensed product [Member] |  |
Summary of milestone payment |  |
Milestones payments | $ 750,000 | $ 750,000
Abbott Biotherapeutics Corp [Member] | Phase II Clinical Trial of a licensed product [Member] |  |
Summary of milestone payment |  |
Milestones payments | 750,000 | 750,000
Abbott Biotherapeutics Corp [Member] | Phase III Clinical Trial of a licensed product [Member] |  |
Summary of milestone payment |  |
Milestones payments | 1,500,000 | 1,500,000
Abbott Biotherapeutics Corp [Member] | Biological License Application filing with U.S. FDA [Member] |  |
Summary of milestone payment |  |
Milestones payments | 1,750,000 | 1,750,000
Abbott Biotherapeutics Corp [Member] | First Commercial Sale [Member] |  |
Summary of milestone payment |  |
Milestones payments | 1,500,000 | 1,500,000
Abbott Biotherapeutics Corp [Member] | After First Net Sales [Member] |  |
Summary of milestone payment |  |
Milestones payments | 1,500,000 | 1,500,000
Memorial Sloan Kettering Cancer Center [Member] | New Drug Application [Member] |  |
Summary of milestone payment |  |
Milestones payments | 750,000 | 750,000
Memorial Sloan Kettering Cancer Center [Member] | Receipt of Regulatory Approval From U.S. FDA [Member] |  |
Summary of milestone payment |  |
Milestones payments | $ 1,750,000 | $ 1,750,000

X
- Definition Long term purchase commitment milestones payment. + References No definition available. + Details
Name: | fil_LongTermPurchaseCommitmentMilestonesPayment
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | fil_MilestonePaymentAbstract
Namespace Prefix: | fil_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration